ALAS1
5-aminolevulinate synthase, non-specific, mitochondrial
Also known as: ALAS, ALAS-H, ALAS3, HEM1_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P13196
- Gene
- ALAS1
- Ensembl
- ENSG00000023330
- Chromosome
- 3
- Canonical length
- 640 aa
- Protein class
- Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Mitochondria
- Quaternary structure
- Homodimer
OverviewNCBI Gene
This gene encodes the mitochondrial enzyme which is catalyzes the rate-limiting step in heme (iron-protoporphyrin) biosynthesis. The enzyme encoded by this gene is the housekeeping enzyme; a separate gene encodes a form of the enzyme that is specific for erythroid tissue. The level of the mature encoded protein is regulated by heme: high levels of heme down-regulate the mature enzyme in mitochondria while low heme levels up-regulate. A pseudogene of this gene is located on chromosome 12. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Jan 2015]
Canonical amino-acid sequenceUniProt
640 residues, UniProt reviewed canonical sequence.
>P13196|ALAS1
1 MESVVRRCPF LSRVPQAFLQ KAGKSLLFYA QNCPKMMEVG AKPAPRALST AAVHYQQIKE
61 TPPASEKDKT AKAKVQQTPD GSQQSPDGTQ LPSGHPLPAT SQGTASKCPF LAAQMNQRGS
121 SVFCKASLEL QEDVQEMNAV RKEVAETSAG PSVVSVKTDG GDPSGLLKNF QDIMQKQRPE
181 RVSHLLQDNL PKSVSTFQYD RFFEKKIDEK KNDHTYRVFK TVNRRAHIFP MADDYSDSLI
241 TKKQVSVWCS NDYLGMSRHP RVCGAVMDTL KQHGAGAGGT RNISGTSKFH VDLERELADL
301 HGKDAALLFS SCFVANDSTL FTLAKMMPGC EIYSDSGNHA SMIQGIRNSR VPKYIFRHND
361 VSHLRELLQR SDPSVPKIVA FETVHSMDGA VCPLEELCDV AHEFGAITFV DEVHAVGLYG
421 ARGGGIGDRD GVMPKMDIIS GTLGKAFGCV GGYIASTSSL IDTVRSYAAG FIFTTSLPPM
481 LLAGALESVR ILKSAEGRVL RRQHQRNVKL MRQMLMDAGL PVVHCPSHII PVRVADAAKN
541 TEVCDELMSR HNIYVQAINY PTVPRGEELL RIAPTPHHTP QMMNYFLENL LVTWKQVGLE
601 LKPHSSAECN FCRRPLHFEV MSEREKSYFS GLSKLVSAQALocalizationUniProt · AlphaFold · HPA
Whether an antibody against ALAS1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.34
- Highest tissue expression
- 697 nTPM
Expression across tissuesHPA
Tissue
- adrenal gland: 697 nTPM
- liver: 513 nTPM
- bone marrow: 167 nTPM
- heart muscle: 110 nTPM
- skeletal muscle: 104 nTPM
- tongue: 100 nTPM
Single-cell type
- adrenal cortex cells: 534 nCPM
- syncytiotrophoblasts: 420 nCPM
- hepatocytes: 282 nCPM
- urothelial cells: 168 nCPM
- esophageal apical cells: 140 nCPM
- mast cells: 133 nCPM
Immune cell
- basophil: 234 nTPM
- eosinophil: 103 nTPM
- neutrophil: 50 nTPM
- intermediate monocyte: 43 nTPM
- non-classical monocyte: 39 nTPM
- MAIT T-cell: 38 nTPM
Brain region
- cerebral cortex: 161 nTPM
- cerebellum: 61 nTPM
- choroid plexus: 57 nTPM
- pons: 52 nTPM
- thalamus: 50 nTPM
- hypothalamus: 41 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.49
- gnomAD pLI
- 0.11
- gnomAD missense Z
- 1.19
- DepMap mean gene effect
- -0.22
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cellular response to insulin stimulus
- erythrocyte development
- heme A biosynthetic process
- heme B biosynthetic process
- heme biosynthetic process
- hemoglobin biosynthetic process
- protoporphyrinogen IX biosynthetic process
- response to bile acid
- response to cAMP
- response to cobalt ion
- response to ethanol
- response to gonadotropin
- response to herbicide
- response to hypoxia
- response to nickel cation
- response to nutrient levels
- response to platinum ion
- response to xenobiotic stimulus
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Aminotransferase, class-II, pyridoxal-phosphate binding site
- Aminotransferase, class I/classII, large domain
- Tetrapyrrole biosynthesis, 5-aminolevulinic acid synthase
- 5-aminolevulinate synthase presequence
- Pyridoxal phosphate-dependent transferase, major domain
- Pyridoxal phosphate-dependent transferase, small domain
- Pyridoxal phosphate-dependent transferase
- 8-amino-7-oxononanoate synthase class-II
- Aminotransferase class I and II
- 5-aminolevulinate synthase presequence
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of ALAS1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ALAS1 as an antibody target. Whether an autoantibody or antibody against ALAS1 could matter depends on whether native ALAS1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ALAS1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label ALAS1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...